Spain in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD08502
Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 146
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Spain in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the Spain In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Spain

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Spain.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Spain.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 In Vitro Diagnostics
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
        • 3.3.1.1 Tumor Markers
        • 3.3.1.2 Cardiac Markers
      • 3.3.2 Disease Specific Test Reagents
        • 3.3.2.1 Auto-Immune Disease
        • 3.3.2.2 Rheumatoid Disease
        • 3.3.2.3 Anemia/ Vitamins
        • 3.3.2.4 Allergy
      • 3.3.3 Drug Related Testing Reagents
        • 3.3.3.1 Therapeutic Drugs
        • 3.3.3.2 Drug of Abuse and Toxicology
      • 3.3.4 Hormone Related Testing Reagents
        • 3.3.4.1 Specific Proteins
        • 3.3.4.2 Fertility and Pregnancy
        • 3.3.4.3 Individual/Specified hormones
        • 3.3.4.4 Specific Organ Function
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
        • 3.4.1.1 Hematology
        • 3.4.1.2 Immunohaematology
        • 3.4.1.3 Hematology Calibrators and Controls
        • 3.4.1.4 Immunohaematology Controls
      • 3.4.2 Hemostasis Test Reagents
        • 3.4.2.1 Hemostasis
        • 3.4.2.2 Hemostasis Calibrators and Controls
        • 3.4.2.3 Hemostasis Rapid Tests
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
        • 3.5.1.1 Bacteriology Culture
        • 3.5.1.2 Blood Culture
        • 3.5.1.3 Bacteriology Identification and Susceptibility
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
        • 3.6.2.1 Hepatitis Viruses
        • 3.6.2.2 Retroviruses
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of medical devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
    • 5.2 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Pricing and Reimbursement Policies
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Spain
    • 8.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
    • 8.3 In Vitro Diagnostics, Spain, Company Share (2006-2007)
  • 9 Blood Test Reagents In Spain
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
      • 9.1.1 Haematology Test Reagents Revenue (2000-2015)
      • 9.1.2 Hemostasis Test Reagents Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, Spain, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Spain
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, Spain, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Spain
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2015)
    • 11.2 Genetic Test Reagents Distribution Share (2007-2008)
    • 11.3 Genetic Test Reagents, Spain, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Spain
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
      • 12.1.1 Disease Specific Markers Revenue (2000-2015)
      • 12.1.2 Disease Specific Test Reagents Revenue (2000-2015)
      • 12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
      • 12.1.4 Hormone Related Testing Reagents Revenue (2000-2015)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 12.3 Immunochemistry Test Reagents, Spain, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Spain
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
      • 13.1.1 Virology Revenue (2000-2015)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 13.3 Infectious Immunology Test Reagents, Spain, Company Share (2006-2007)
  • 14 Instruments In Spain
    • 14.1 Instruments Overall Revenue (2000-2015)
    • 14.2 Instruments Distribution Share (2007-2008)
  • 15 Microbiology Test Reagents In Spain
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2015)
      • 15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
    • 15.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 15.3 Microbiology Test Reagents, Spain, Company Share (2006-2007)
  • 16 Self Testing In Spain
    • 16.1 Self Testing Overall Revenue (2000-2015)
    • 16.2 Self Testing Distribution Share (2007-2008)
    • 16.3 Self Testing, Spain, Company Share (2006-2007)
  • 17 Overview of Key Companies in Spain In Vitro Diagnostics Market
    • 17.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 17.1.1 Company Overview
      • 17.1.2 Value Chain Analysis
        • 17.1.2.1 Manufacturing
        • 17.1.2.2 Product Development
    • 17.2 Abbott Laboratories Company Profile
      • 17.2.1 Company Overview
      • 17.2.2 Value Chain Analysis
        • 17.2.2.1 Manufacturing
        • 17.2.2.2 Product Development
        • 17.2.2.3 Sales and Marketing
    • 17.3 Beckman Coulter, Inc. Company Profile
      • 17.3.1 Company Overview
      • 17.3.2 Value Chain Analysis
        • 17.3.2.1 Manufacturing
        • 17.3.2.2 Product Development
        • 17.3.2.3 Sales and Marketing
      • 17.3.3 Beckman Coulter, Inc. Pipeline Products
        • 17.3.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
        • 17.3.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
        • 17.3.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
        • 17.3.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary
    • 17.4 Dade Behring Holdings, Inc. Company Profile
      • 17.4.1 Company Overview
    • 17.5 bioMerieux S.A. Company Profile
      • 17.5.1 Company Overview
      • 17.5.2 Value Chain Analysis
        • 17.5.2.1 Manufacturing
        • 17.5.2.2 Product Development
        • 17.5.2.3 Sales and Marketing
    • 17.6 Ortho-Clinical Diagnostics Inc. Company Profile
      • 17.6.1 Company Overview
      • 17.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
        • 17.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type
        • 17.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
        • 17.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
        • 17.6.2.4 Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • 17.7 OLYMPUS CORPORATION Company Profile
      • 17.7.1 Company Overview
      • 17.7.2 Value Chain Analysis
        • 17.7.2.1 Manufacturing
        • 17.7.2.2 Product Development
        • 17.7.2.3 Sales and Marketing
      • 17.7.3 Olympus Medical Systems Corp. Pipeline Products
        • 17.7.3.1 Olympus Medical Systems Corp. Pipeline Products by Equipment Type
        • 17.7.3.2 Olympus Medical Systems Corp. Pipeline Products by Development Stage
        • 17.7.3.3 Olympus Medical Systems Corp. Pipeline Products by Therapy Area
        • 17.7.3.4 Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
        • 17.7.3.5 Olympus Medical Systems Corp. Pipeline Products by News Summary
    • 17.8 Gen-Probe Incorporated Company Profile
      • 17.8.1 Company Overview
      • 17.8.2 Value Chain Analysis
        • 17.8.2.1 Manufacturing
        • 17.8.2.2 Product Development
        • 17.8.2.3 Sales and Marketing
      • 17.8.3 Gen-Probe Incorporated Pipeline Products
        • 17.8.3.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
        • 17.8.3.2 Gen-Probe Incorporated Pipeline Products By Development Stage
        • 17.8.3.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
        • 17.8.3.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
        • 17.8.3.5 Gen-Probe Incorporated Pipeline Products By News Summary
    • 17.9 Becton, Dickinson and Company Profile
      • 17.9.1 Company Overview
      • 17.9.2 Value Chain Analysis
        • 17.9.2.1 Manufacturing
        • 17.9.2.2 Product Development
        • 17.9.2.3 Sales and Marketing
    • 17.10 Digene Corporation Company Profile
      • 17.10.1 Company Overview
    • 17.11 Siemens Healthcare Company Profile
      • 17.11.1 Company Overview
      • 17.11.2 Value Chain Analysis
        • 17.11.2.1 Manufacturing
        • 17.11.2.2 Product Development
        • 17.11.2.3 Sales and Marketing
    • 17.12 SPINREACT, S.A
      • 17.12.1 Company Overview
  • 18 Grifols, S.A. Company Profile
    • 18.1.1 Company Overview
  • 19 Financial Deals Landscape
  • 19.1 Partnerships
    • 19.1.1 Biotools, B & M Labs Enters Into an Agreement with Diapro
  • 20 Appendix
  • 20.1 Global Markets Direct Research Methodology
  • 20.2 Coverage
  • 20.3 Secondary Research
  • 20.4 Primary Research
  • 20.5 Models
  • 20.6 Forecasts
  • 20.7 Expert Panel Validation
  • 20.8 Currency Conversion
  • 20.9 Contact Us
  • 20.10 Disclaimer
  • 1 List of Tables
  • Table 1: Number of Doctors by Specialty in Spain, 2003-2007
  • Table 2: Number of Hospital Wards by Specialty in Spain, 2003-2007
  • Table 3: Healthcare Institutions in Spain, 2005
  • Table 4: Hospital Beds by Type in Spain, 2005
  • Table 5: Number of Healthcare Personnel in Spain, 2005
  • Table 6: Number of Medical Equipment in Spain, 2005
  • Table 7: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
  • Table 8: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
  • Table 9: In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015
  • Table 10: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
  • Table 11: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
  • Table 12: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 13: Blood Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Table 14: Blood Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Table 15: Haematology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 16: Haematology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 17: Hemostasis Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 18: Hemostasis Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 19: Blood Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 20: Blood Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 21: Clinical Chemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Table 22: Clinical Chemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Table 23: Clinical Chemistry Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 24: Clinical Chemistry Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 25: Genetic Test Reagents, Spain, Revenue ($ mn), Historic, 2000-2008
  • Table 26: Genetic Test Reagents, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Table 27: Genetic Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 28: Genetic Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 29: Immunochemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Table 30: Immunochemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Table 31: Disease Specific Markers, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 32: Disease Specific Markers, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 33: Disease Specific Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 34: Disease Specific Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 35: Drug Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 36: Drug Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 37: Hormone Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 38: Hormone Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 39: Immunochemistry Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 40: Immunochemistry Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 41: Infectious Immunology Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Table 42: Infectious Immunology Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Table 43: Virology, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 44: Virology, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 45: Infectious Immunology Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 46: Infectious Immunology Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 47: Instruments, Spain, Revenue ($ mn), Historic, 2000-2008
  • Table 48: Instruments, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Table 49: Instruments, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 50: Microbiology Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Table 51: Microbiology Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Table 52: Bacteriology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Table 53: Bacteriology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Table 54: Microbiology Test Reagents, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 55: Microbiology Test Reagents, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 56: Self Testing, Spain, Revenue ($ mn), Historic, 2000-2008
  • Table 57: Self Testing, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Table 58: Self Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008
  • Table 59: Self Testing, Spain, Company Share by Revenue ($ mn), 2006-2007
  • Table 60: Beckman Coulter, Inc. Pipeline Products by Equipment Type
  • Table 61: Beckman Coulter, Inc. Pipeline Products By Development Stage
  • Table 62: Beckman Coulter, Inc. Pipeline Products By Therapy Area
  • Table 63: Beckman Coulter, Inc. Pipeline Products By News Summary
  • Table 64: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
  • Table 65: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
  • Table 66: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
  • Table 67: Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
  • Table 68: Olympus Medical Systems Corp. Pipeline Products by Equipment Type
  • Table 69: Olympus Medical Systems Corp. Pipeline Products by Development Stage
  • Table 70: Olympus Medical Systems Corp. Pipeline Products by Therapy Area
  • Table 71: Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
  • Table 72: Olympus Medical Systems Corp. Pipeline Products by News Summary
  • Table 73: Gen-Probe Incorporated Pipeline Products by Equipment Type
  • Table 74: Gen-Probe Incorporated Pipeline Products By Development Stage
  • Table 75: Gen-Probe Incorporated Pipeline Products By Therapy Area
  • Table 76: Gen-Probe Incorporated Pipeline Products By Clinical Trials
  • Table 77: Gen-Probe Incorporated Pipeline Products By News Summary
  • Table 78: Biotools, B & M Labs Enters Into An Agreement With Diapro
  • Table 79: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
  • Figure 1: Total Healthcare Expenditure in Spain, 2000 2006
  • Figure 2: Flowchart for Classification of Non-invasive Devices in Spain, 2007
  • Figure 3: Flowchart for Classification of Invasive Devices in Spain, 2007
  • Figure 4: Flowchart for Classification of Invasive Devices in Spain, 2007
  • Figure 5: Flowchart for Classification of Invasive Devices in Spain, 2007
  • Figure 6: Flowchart for Classification of Invasive Devices in Spain, 2007
  • Figure 7: Flowchart for Classification of Active Devices in Spain, 2007
  • Figure 8: Flowchart for Classification of Active Devices in Spain, 2007
  • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Spain, 2007
  • Figure 10: Conformity Assessment of Class-I Medical Devices in Spain, 2007
  • Figure 11: Conformity Assessment of Class-IIa Medical Devices in Spain, 2007
  • Figure 12: Conformity Assessment of Class-IIb Medical Devices in Spain, 2007
  • Figure 13: Conformity Assessment of Class-III Medical Devices in Spain, 2007
  • Figure 14: In Vitro Diagnostics Cross Country Comparison , Revenue ($ mn), 2000-2015
  • Figure 15: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
  • Figure 16: In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015
  • Figure 17: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
  • Figure 18: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
  • Figure 19: In Vitro Diagnostics, Spain, Company Share (%), 2007
  • Figure 20: Blood Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Figure 21: Blood Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Figure 22: Haematology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 23: Haematology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 24: Hemostasis Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 25: Hemostasis Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 26: Blood Test Reagents, Spain, Company Share (%), 2007
  • Figure 27: Clinical Chemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Figure 28: Clinical Chemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Figure 29: Clinical Chemistry Test Reagents, Spain, Company Share (%), 2007
  • Figure 30: Genetic Test Reagents, Spain, Revenue ($ mn), Historic, 2000-2008
  • Figure 31: Genetic Test Reagents, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Figure 32: Genetic Test Reagents, Spain, Company Share (%), 2007
  • Figure 33: Immunochemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Figure 34: Immunochemistry Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Figure 35: Disease Specific Markers, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 36: Disease Specific Markers, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 37: Disease Specific Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 38: Disease Specific Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 39: Drug Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 40: Drug Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 41: Hormone Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 42: Hormone Related Testing Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 43: Immunochemistry Test Reagents, Spain, Company Share (%), 2007
  • Figure 44: Infectious Immunology Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Figure 45: Infectious Immunology Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Figure 46: Virology, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 47: Virology, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 48: Infectious Immunology Test Reagents, Spain, Company Share (%), 2007
  • Figure 49: Instruments, Spain, Revenue ($ mn), Historic, 2000-2008
  • Figure 50: Instruments, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Figure 51: Microbiology Test Reagents, Spain, Revenue ($ mn) by Segment , Historic, 2000-2008
  • Figure 52: Microbiology Test Reagents, Spain, Revenue ($ mn) by Segment , Forecast, 2008-2015
  • Figure 53: Bacteriology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
  • Figure 54: Bacteriology Test Reagents, Spain, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
  • Figure 55: Microbiology Test Reagents, Spain, Company Share (%), 2007
  • Figure 56: Self Testing, Spain, Revenue ($ mn), Historic, 2000-2008
  • Figure 57: Self Testing, Spain, Revenue ($ mn), Forecast, 2008-2015
  • Figure 58: Self Testing, Spain, Company Share (%), 2007
  • Figure 59: F. Hoffmann-La Roche Ltd Value Chain Analysis
  • Figure 60: Abbott Laboratories Value Chain Analysis
  • Figure 61: Beckman Coulter, Inc. Value Chain Analysis
  • Figure 62: Biomerieux Sa Value Chain Analysis
  • Figure 63: Olympus Medical Systems Corp. Value Chain Analysis
  • Figure 64: Gen-Probe Incorporated Value Chain Analysis
  • Figure 65: Becton, Dickinson and Company Value Chain Analysis
  • Figure 66: Siemens Medical Solutions Value Chain Analysis
  • Figure 67: Global Markets Direct Methodology